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a  b  s  t  r  a  c  t
Currently  Streptomyces  is  one  of  the  most  important  antibiotic  producing  microorganisms  against  sev-
eral diseases.  In  the present  study  Streptomyces  olivochromogenes  ERINLG-261  was isolated  from  the soil
samples  of  the  Mudumalai  hills,  Western  Ghats,  India.  Morphological,  physiological,  biochemical  and
16S rRNA  studies  strongly  suggested  that  this  isolate  belonged  to  the genus  Streptomyces. ERINLG-261
showed  good  antimicrobial  activity  against  different  bacteria  and  fungi  in Micromonospora  fermentation
medium.  The  active  ethyl  acetate  extract  was  packed  in  column  chromatography  over silica  gel  which
led  to the  isolation  of 2-hydroxy-9,10-anthraquinone  as  the  active  principle.  The  isolated  compound
showed  good  antimicrobial  activity  against  tested  bacteria  and  fungi  in  minimum  inhibitory  concen-
tration  (MIC)  and  minimum  bactericidal  concentration  (MBC)  studies.  The  compound  showed  moderate
in vitro  antiproliferative  activity  against  A549  and  COLO320  cells.  The  compound  was  subjected  to  molec-
ular  docking  studies  for the  inhibition  of Topoisomerase,  TtgR  and  Beta-lactamase  enzymes  which  are
targets  for  antimicrobials.  Docking  results  of  the  compound  showed  low  docking energy  with these
enzymes  indicating  its  usefulness  as  antimicrobial  agent.  This  is  the  ﬁrst report of  antimicrobial  and
antiproliferative  activity  of  2-hydroxy-9,10-anthraquinone  isolated  from  Streptomyces  olivochromogenes
along  with  molecular  docking  studies.
© 2016 Sociedade  Brasileira  de  Farmacognosia.  Published  by Elsevier  Editora  Ltda.  All  rights  reserved.ntroduction
Actinomycetes have been especially useful to the pharmaceu-
ical industry for their seemingly unlimited capacity to produce
econdary metabolites with diverse chemical structures and bio-
ogical activities. Actinomycetes are Gram-positive ﬁlamentous
acteria, characterized by a complex morphologic differentiation
ycle accompanied by the production of numerous extracel-
ular enzymes as well as many kinds of bioactive secondary
etabolites having great structural and functional diversity
∗ Corresponding author.
E-mail: balasang@fujita-hu.ac.jp (C. Balachandran).
http://dx.doi.org/10.1016/j.bjp.2015.12.003
102-695X/© 2016 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editora(Williams et al., 1983). Actinomycetes are known producers of
structurally diverse metabolites namely, -lactam antibiotics,
thienamycin, macrolides, streptomycin, erythromycin, anthracy-
clines, daunorubicin, doxorubicin, polyketides, rapamycin, FK-506,
peptide antibiotics, virginiamycin, pristinamycin, aminoglycosides,
gentamicin and kanamycin (Demain, 1999). Secondary metabo-
lites are potent antibiotics which have made Streptomyces the
primary antibiotic producing organisms exploited by the pharma-
ceutical industry (Raja and Prabakaran, 2011). Streptomyces is one
of the most major sources of antibiotic producing microorgan-
isms and back-bone for curing important diseases. Streptomyces
are known to be producers of many secondary metabolites
which have different biological activities such as antibacterial,
antifungal, antiparasitic, antitumor, inﬂammatory responses and
 Ltda. All rights reserved.
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mmunosuppressive actions (Demain, 1999; Sanghvi et al., 2014;
ambabu et al., 2014; Balachandran et al., 2015). In recent
imes, Streptomyces has been called as antibiotic store room or
ibrary. More than 23,000 bioactive secondary metabolites pro-
uced by microorganisms have been reported and over 10,000
f these compounds are produced by actinomycetes (Raja and
rabakaran, 2011). Among actinomycetes, around 7600 com-
ounds are produced by Streptomyces species (Raja and Prabakaran,
011). Aouiche et al. (2014) had reported saquayamycins iso-
ated from Streptomyces spp. PAL114 which showed good activity
gainst Candida albicans M3  and Bacillus subtilis ATCC 6633. Huang
t al. (2015) reported the isolation of new compounds and four
nown compounds were isolated from the marine Streptomyces
riseus RSH0407 such as butyl homononactate, butyl nonactate,
-actyl homononactic acid, homononactic acids, nonactic acid,
omononactyl nonactate, homononactyl homononactate. Among
hese seven compounds butyl homononactate showed good cyto-
oxic properties against HCT-8, A2780, BGC-823, BEL-7402, and
549 cells.
Naturally occurring anthraquinones form the largest group
f plant and microbial secondary metabolites. Anthraquinone
erivatives are well recognized as important biologically active
omponents from microbes and plants (Anke et al., 1980). The
nthraquinones type of compounds showed activity against certain
iseases including antifungal, antibacterial, anticancer, antioxi-
ant, antiviral, anti-inﬂammatory and antihuman cytomegalovirus
Barnard et al., 1995; Agarwal et al., 2000; Iizuka et al., 2004; Chen
t al., 2007; Ifesan et al., 2009). In the present study antibacterial,
ytotoxic and molecular docking properties of 2-hydroxy-9,10-
nthraquinone (1) isolated from Streptomyces olivochromogenes
ERINLG-261) were assessed.
aterials and methods
solation of Streptomyces olivochromogenes
The soil samples were collected from the depth of 5–15 cm at
udumalai hills, Nilgiris, Western Ghats of Tamil Nadu, India. Iso-
ation of Streptomyces olivochromogenes was performed by serial
ilution using dilution plate technique (Balachandran et al., 2014a).
orphological and biochemical observations
Cultural and morphological features of ERINLG-261 were char-
cterized following the directions given by the ISP (Shirling and
ottlieb, 1966) and the Bergey’s Manual of Systematic Bacteriology.
ultural characteristics of pure isolates in various media (ISP 1–7)
ere recorded after incubation at 30 ◦C for 7–14 days. The shape of
ell, Gram-stain, color, the presence of spores and colony morphol-
gy were assessed on solid ISP agar medium. Biochemical reactions,
ifferent temperatures, NaCl concentration, pH level, pigment pro-
uction, enzyme reaction and acid or gas production were done
ollowing the methods of Balachandran et al. (2012, 2014a,b).
6S rRNA gene ampliﬁcation
Genomic DNA of ERINLG-261 was isolated using the meth-
ds of Hipura Streptomyces DNA spin kit-MB 527-20pr from
i-media. The 16S ribosomal RNA gene was ampliﬁed by PCR
ethod using primers 27f (51AGTTTGATCCTGGCTCAG31) and
492r (51ACGGCTACCTTGTTACGACTT31). Each PCR mixture in a
nal volume of 20 l contained 10 mM Tris–HCl (pH.8.3), 50 mM
Cl, 1.5 mM MgCl2, 200 M of each dNTP, 10 pmol of each primer,
0 ng of genomic DNA and 1 U of Taq DNA Polymerase (New
ngland Biolabs Inc). PCR ampliﬁcation was detected by 1% agarose Farmacognosia 26 (2016) 285–295
gel electrophoresis and was  visualized by ultraviolet (UV) ﬂuores-
cence after ethidium bromide staining. The PCR product obtained
was sequenced by an automated sequencer (Genetic Analyser 3130,
Applied Biosystem, and USA). The same primers as above were used
for this purpose. The sequence was compared for similarity with the
reference species of bacteria contained in genomic database banks
using the NCBI BLAST available at http://www.ncbinlm-nih.gov/.
The partial 16S rRNA gene sequence of isolate ERINLG-261 has
been deposited in the GenBank database under accession number
KF061091. A phylogenetic tree was  constructed using the neighbor-
joining DNA distance algorithm using software MEGA (version 4.1)
(Tamura et al., 2007).
Primary antimicrobial screening
Primary antimicrobial activity was  evaluated on Modiﬁed Nutri-
ent Glucose Agar medium (MNGA) by the cross streak method
against various pathogenic microorganisms (Balachandran et al.,
2014b).
Media optimization
Four fermentation media were used for media optimization
such as Streptomyces media-1 (tryptone: 17 g, peptone: 3 g, NaCl:
5 g, K2HPO4: 1.25 g, pH 7 and H2O: 1000 ml), Nutrient Glucose
media-2 (glucose: 10 g, peptone: 5 g, yeast extract: 3 g, NaCl: 3 g,
beef extract: 3 g, pH 7 and H2O: 1000 ml), Bennett media-3 (glu-
cose: 10 g, peptone: 2 g, yeast extract: 1 g, malt extract: 1 g, pH 7
and H2O: 1000 ml), Micromonospora media-4 (glucose: 10 g, starch:
24 g, peptone: 3 g, meat extract: 3 g, yeast extract: 5 g, CaCO3: 4 g,
pH 7 and H2O: 1000 ml). Active culture ERINLG-261 was inocu-
lated in these four fermentation media and incubated for 0 day, 2nd
day, 4th day, 6th day, 8th day, 10th day and 12th day. After incuba-
tion secondary metabolites were extracted using CHCl3, EtOAc and
butanol (1:1 v/v). All the extracts were checked for antimicrobial
activity against bacteria and fungi.
Extraction of secondary metabolites
Culture inoculate of the isolate ERINLG-261 was taken in 500 ml
Erlenmeyer ﬂasks containing 150 ml  of media-4 and incubated at
30 ◦C in a shaker (200 rpm) for 10 days. After 10th day the culture
broth was centrifuged at 8000 × g for 20 min  to remove the biomass.
Equal volume of CHCl3, EtOAc and butanol (1:1 v/v) were added
and shaken in a separating funnel. The process was repeated thrice
and the extracts were combined. The extract was  dried over anhy-
drous sodium sulphate and distilled in a rotary evaporator and the
red residue obtained was  ﬁnally dried in vacuum. The secondary
metabolite production was  continued up to 20 l.
Column chromatography
The active EtOAc extract (9 g) was  subjected to silica gel col-
umn  chromatography (Acme’s 100–200 mesh) (column size-60 cm
length/2.5 cm). The column was successively eluted with hexane,
hexane:EtOAc mixtures with increasing polarity and ﬁnally with
EtOAc:MeOH and MeOH (each fraction being 100 ml). Based on
thin layer chromatography (TLC) proﬁles, the fractions were com-
bined to give seventeen fractions. All these fractions were subjected
to antimicrobial screening against bacteria and fungi. Among the
seventeen fractions, fraction number 6 showed good antimicrobial
activities against tested bacteria and fungi. In further active fraction
6 (yield 560 mg)  was  subjected to preparative high-performance
liquid chromatography (HPLC) analysis. HPLC with isocratic elu-
tion capability H2O alliance system was  used. Column length was
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Table  1
Culture characteristics of Streptomyces olivochromogenes (ERINLG-261) in different media.
Medium Growth Substrate mycelium Aerial mycelium Spores Pigment color
ISP 1 Good Golden yellow Dark gray Present Red
ISP  2 Good Golden yellow Dark gray Present Red
ISP  3 Good Yellow Gray Moderate Red
ISP  4 Good Yellow Gray Present Light red
ISP  5 Good Yellow Gray Present Red
ISP  6 Good Yellow Gray Present Light red
ISP  7 Poor Poor Gray Poor Moderate
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found to be without visual turbidity. The MBC  was  considered as
the lowest concentration of isolated compound which prevented
growth and reduced the inoculum by ≥99.9% within 24 h, irrespec-
tive of counts of survivors at higher antibiotic concentrations and
Table 2
Physiological and biochemical characteristics of Streptomyces olivochromogenes
(ERINLG-261).
Characteristics Results
Gram staining Positive
Shape and growth Filamentous aerial growth
Production of diffusible pigment +
Range of temperature for growth 25–37 ◦C
Optimum temperature 30 ◦C
Range of pH for growth 6–10
Normal pH 7
H2S production −
Amylase +
Chitinase +
Protease +
Gelatinase −
Indole production +
Growth in the presence of NaCl 1–7%
Sugar analysis
Glucose ++
Galactose +
Lactose −
Mannitol −
Sucrose ++
Xylose +
Rhamnose ++
Ribose +
Arabinose −
Mannose ++
Maltose ++
Starch ++
Standard antibiotics
Ciproﬂoxacin S
Gentamicin S
Ampicillin S
Cephaloridine S
Streptomycin S
Erythromycin S
Vencomycin S
Amikacin SMNGA Good Yellow 
SP 1–7: International Streptomyces Project; MNGA: modiﬁed nutrient glucose agar
50 mm with internal diameter of 6.0 mm and was ﬁlled with sil-
ca particles of 15 m diameter bonded with octadecylsilane (YMC
ack ODS A (250 × 6.0 mm),  15 m).  The mobile phase was  com-
osed of ACN and aqueous HOAc (15:85, v/v); it was isocratically
luted at a ﬂow-rate of 3 ml/min and injection volume was 100 l.
lution was monitored at 254 nm and peak fraction was collected
ccording to the elution proﬁle. The pure compound was obtained
s yellow crystal from MeOH (97.66%) (retention time 14.008 and
lution time 20 min).
icrobial organisms
The following Gram negative and Gram positive bacteria, clin-
cal isolates and fungi were used for the experiment. Seven
ram negative bacteria: Enterobacter aerogenes MTCC 111, Shigella
exneri MTCC 1457, Salmonella paratyphi-B, Klebsiella pneumonia
TCC 109, Pseudomonas aeruginosa MTCC 741, Proteus vulgaris
TCC 1771 and Salmonella typhimurium MTCC 1251; four Gram
ositive bacteria: Bacillus subtilis MTCC 441, Micrococcus luteus
TCC 106, Staphylococcus aureus MTCC 96 and Staphylococcus
pidermidis MTCC 3615; seven clinical isolates (isolated from
atient’s urine samples): Escherichia coli (ESBL-3984, Extended
pectrum Beta Lactamase), Escherichia coli (ESBL-3904), Klebsiella
neumoniae (ESBL-3971), Klebsiella pneumoniae (ESBL-75799),
lebsiella pneumoniae (ESBL-3894), Klebsiella pneumoniae (ESBL-
967) and Staphylococcus aureus (MRSA− methicillin resistant,
linical pathogen). The reference cultures were obtained from the
nstitute of Microbial Technology (IMTECH), Chandigarh, India-
60 036; Candida albicans MTCC 227, Malassesia pachydermatis and
spergillus ﬂavus were obtained from the Department of Microbiol-
gy, Christian Medical College, Vellore, Tamil Nadu, India. Bacterial
noculums were prepared by growing cells in Mueller Hinton broth
MHB) (Himedia) for 24 h at 37 ◦C. The ﬁlamentous fungi were
rown on Sabouraud dextrose agar (SDA) slants at 28 ◦C for 10 days
nd the spores were collected using sterile doubled distilled water
nd homogenized. Yeast was grown on Sabouraud dextrose broth
SDB) at 28 ◦C for 48 h.
ntimicrobial assay
Antibacterial and antifungal activities were carried out using
isk diffusion method (Balachandran et al., 2013). Zones of inhibi-
ion were recorded in millimeters and the experiment was  repeated
hrice.
inimum inhibitory concentration (MIC)
MIC  studies of the isolated compound were performed accord-
ng to the standard reference methods for bacteria (Balachandran
t al., 2014a,b), ﬁlamentous fungi (CLSI, 2008), and yeasts (NCCLS,
999, 2002). The required concentrations (100, 50, 25, 12.5, 6.25
nd 3.125 g/ml) of the compound were dissolved in DMSO.Dark gray Present Light red
esent. −: absent.
Minimum bactericidal concentration (MBC)
Freshly prepared tubes containing serial twofold dilutions of
the compound in 5 ml  of MHB  (range, 100, 50, 25, 12.5, 6.25 and
3.13 g/ml) were inoculated beneath the surface with 5 × 105 to
1 × 106 cells in 0.1 ml  of MHB, mixed by ﬂushings and incubated
without shaking or agitation. After 20 h of incubation, all broths
were examined for visual turbidity or growth of small colonies
at the bottom of tubes and again vortexed. The tubes were re-
incubated for a further 4 h and vortexed again until all tubes werePenicillin S
Rifamycin S
Norﬂoxacin S
+: presence; −: absence; S: sensitive; R: resistance.
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 KF061091/ERINLG-261/ (Streptomyces ol...
 FJ007405.1| Streptomyces scabiei
 AB741446.1| Streptomyces olivochromog...
 HE577950.1| Streptomyces sp. IMCr03 C...
 JQ670769.1| Streptomyces sp. 075013 C...
 EU360178.1| Streptomyces sp. 18(2008)...
 JQ289352.1| Streptomyces sp. GCTTACCA...
 JX312315.1| Streptomyces sp. MCR26 CA...
 FJ532409.1| Streptomyces olivochromog...
 AB184737.1| Streptomyces olivochromog...
 EU603343.1| Streptomyces sp. MJM3509 ...
 GU045529.1| Streptomyces sp. SXY43 AT...
 HE617217.1| Streptomyces sp. CTTAACAC...
 JN866626.1| Streptomyces sp. TGCAGTCG...
 EU370088.1| Streptomyces sp. AGTCGAAC...
 EU054368.1| Streptomyces sp. ACATGCAG...
 HQ398415.1| Streptomyces sp. CO178 AC...
 AB045868.1| Streptomyces fimbriatus G...
 JF728875.1| Streptomyces chartreusis ...
 HQ607437.1| Streptomyces flavovariabi...
 FJ481059.1| Streptomyces chartreusis ...
 FJ796459.1| Streptomyces pseudovenezu...
 GQ924491.1| Streptomyces sp. GSENDO-0...
 AJ399481.1| Streptomyces pseudovenezu...
 JF439617.1| Streptomyces plumbiresist...
 EU603348.1| Streptomyces sp. MJM4120 ...
 FR692114.1| Streptomyces sp. BK189 TT...
 AF112159 Streptomyces sp. EF-52 TCACG...
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dig. 1. Phylogenetic tree derived from 16S rRNA gene sequences showing the re
elonging to the genus Streptomyces constructed using the neighbor-joining metho
he lowest concentration of the compound inhibiting the visual
rowth of the test cultures on the agar plate. For fungi, the plates
ere incubated for 48–72 h at 28 ◦C and for bacteria the plates were
ncubated for 24 h at 37 ◦C (Chennakesava Rao et al., 2014).
ytotoxic properties
A549 lung adenocarcinoma cancer cell line and COLO320 can-
er cell line were obtained from National Institute of Cell Sciences,
une. A549 cell line was  maintained in complete tissue cul-
ure medium Dulbecco’s Modiﬁed Eagle’s Medium (DMEM) and
OLO320 cancer cell line Roswell Park Memorial Institute medium
RPMI) with 10% Fetal Bovine Serum and 2 mM l-Glutamine, along
ith antibiotics (about 100 International Unit/ml of penicillin,
00 g/ml of streptomycin) with the pH adjusted to 7.2. The cyto-
oxicity was determined according to the method (Saravana Kumar
t al., 2014) with some changes. Cells (5000 cells/well) were seeded
n 96 well plates containing medium with different concentrations
uch as 500, 400, 300, 200, and 100 g/ml. The cells were culti-
ated at 37 ◦C with 5% CO2 and 95% air in 100% relative humidity.
fter various durations of cultivation, the solution in the medium
as removed. An aliquot of 100 l of medium containing 1 mg/ml
f 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide
as loaded in the plate. The cells were cultured for 4 h and then the
olution in the medium was removed. An aliquot of 100 l of DMSO
as added to the plate, which was shaken until the crystals were
issolved. The cytotoxicity against cancer cells was determined byhip between Streptomyces olivochromogenes (ERINLG-261) and the other species
tstrap values were expressed as percentages of 1000 replications.
measuring the absorbance of the converted dye at 540 nm in an
enzyme linked immune sorbant assay reader. Cytotoxicity of each
sample was expressed as the half maximal inhibitory concentration
(IC50) value. The IC50 value is the concentration of test sample that
causes 50% inhibition of cell growth, averaged from three replicate
experiments. The percentage of growth inhibition was calculated
using the following formula; inhibition (%) = A − B/A × 100 (A – Con-
trol group and B – Treated group).
Molecular docking studies
Molecular docking studies were done using the AutoDock Tools
(ADT) version 1.5.6 and AutoDock version 4.2.5.1 docking program.
Docking studies were performed by Intel® core i5 CPU (2.53 GHz)
with Windows 7 operating system.
Protein structure preparation
Docked receptor structures of DNA Topoisomerase IV (PDB ID:
4EMV), TtgR (PDB ID: 2UXO) and beta lactamase (PDB ID: 4NK3)
were obtained from the Protein Data Bank. The co-crystallized
ligand in the receptor crystal structure was removed. Then the
polar hydrogen atoms were added, lower occupancy residue
structures were deleted, and any incomplete side chains were
replaced using the ADT. Further ADT was used to remove crys-
tal water; Gasteiger charges were added to each atom, and
merged the non-polar hydrogen atoms to the protein structure. The
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istance between donor and acceptor atoms that formed a hydro-
en bond was deﬁned as 1.9 A˚ with a tolerance of 0.5 A˚, and the
cceptor–hydrogen–donor angle was not less than 120◦. The struc-
ures were then saved in PDBQT ﬁle format, for further studies
n ADT.
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ig. 2. Antimicrobial activities of chloroform, ethyl acetate and butanol extract of Streptom
o  -4 using disk diffusion method (zone of inhibition in mm)  (5 mg/disk). (A) Fermentation m
edia-4. Values in each column followed by the same alphabets are not signiﬁcantly d
gent;  ketoconazole – standard antifungal agent. Farmacognosia 26 (2016) 285–295 289
Ligand structure preparationLigand 2D structure was  drawn using ChemDraw Ultra 12.0
(ChemOfﬁce, 2010). Chem3D Ultra 12.0 was used to convert
2D structure into 3D and the energy was minimized using
form
m
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m
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Control
yces olivochromogenes (ERINLG-261) extracted from different fermentation media-1
edia-1, (B) Fermentation media-2, (C) Fermentation media-3 and (D) Fermentation
ifferent by Duncan test at p ≤ 0.05. Control-Streptomycin – standard antibacterial
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emi-empirical AM1 method. Minimized energy to minimum RMS
radient of 0.100 was set in each iteration. All structures were saved
s PDB ﬁle format for input to ADT. All the ligand structures were
hen saved in PDBQT ﬁle format, to carry out docking in ADT.
rid formation
A grid box with dimension of 40 × 40 × 40 A˚3 with 0.375 A˚ spac-
ng and centered on (x,y,z) 14.789, 29.446, 7.080; 0.856, 34.778,
3.333 and 5.475, 13.239, 18.265 was created around the binding
ite of ligand on DNA Topoisomerase IV (PDB ID: 4EMV), TtgR (PDB
D: 2UXO) and beta lactamase (PDB ID: 4NK3), respectively, using
DT. The center of the box was set at ligand center and grid energy
alculations were carried out.
ocking protocol
For the AutoDock docking calculation, default parameters were
sed and 50 docked conformations were generated for each
ompound. The energy calculations were done using genetic algo-
ithms. The outputs were exported to PyMol for visual inspection of
he binding modes and interactions of the compounds with amino
cid residues in the active sites (PyMOL, 2010).
tatistical analysis
Antimicrobial and cytotoxic activities of 2-hydroxy-9,10-
nthraquinone (1) were statistically analyzed by Duncan multiple
ange test at p = 0.05 with the help of SPSS 11.5 version software
ackage.
able 3
inimum inhibitory concentration and minimum bactericidal concentration of
-hydroxy-9,10-anthraquinone from Streptomyces olivochromogenes (ERINLG-261)
gainst bacteria and fungi.
Organism MIC  (g/ml) MBC  (g/ml) Streptomycin
Gram negative
E. aerogenes 50 50 25
K.  pneumoniae 50 50 25
P.  vulgaris 12.5 25 6.25
P.  aeruginosa 12.5 12.5 25
S.  paratyphi-B 25 25 6.25
S.  typhimurium 25 25 25
S.  ﬂexneri 12.5 12.5 6.25
Gram positive
B. subtilis >100 >100 12.5
M.  luteus >100 >100 6.25
S.  aureus >100 >100 6.25
S.  epidermidis 50 100 –
Clinical isolates
E. coli (ESBL-3984) 25 25 25
E.  coli (ESBL-3904) 50 100 25
K.  pneumoniae
(ESBL-3971)
12.5 12.5 6.25
K.  pneumoniae
(ESBL-75799)
50 50 25
K.  pneumoniae
(ESBL-3894)
>100 >100 6.25
K.  pneumoniae
(ESBL-3967)
>100 >100 25
S.  aureus (MRSA) 50 100 6.25
Fungi Ketoconazole
C.  albicans 50 100 25
A.  ﬂavus >100 >100 12.5
M.  pachydermatis 25 50 15
treptomycin – standard antibacterial agent; ketoconazole – standard antifungal
gent. Farmacognosia 26 (2016) 285–295
Results and discussion
Morphology and biochemical studies
We  were isolated 25 strains from different soil samples of
the Mudumalai hills, Nilgiris, Western Ghats of Tamil Nadu, India
using humic acid vitamin agar medium. Among the 25 isolates
ERINLG-261 strain showed good antimicrobial activity in pre-
liminary screening. This strain was  Gram-positive ﬁlamentous
bacterium. The color of the substrate mycelia was  golden yellow
(Table 1). ERINLG-261 showed good growth on medium amended
with sodium chloride up to 7%; no growth was seen at 9%. The
temperature for growth ranged from 25 to 37 ◦C with optimum
of 30 ◦C and the pH range was  6–10 with optimal pH of 7. Uti-
lization of various carbon sources by ERINLG-261 indicated a wide
pattern of carbon source assimilation. Starch, maltose, mannose,
rhamnose, sucrose and glucose supported the growth of the strain.
ERINLG-261 showed sensitivity in all tested antibiotics (Table 2).
The culture, morphological characteristics and antimicrobial activ-
ities of different Streptomyces isolates have been reported by several
investigators (Oskay et al., 2004).
16S rRNA gene ampliﬁcation
The result of the sequencing of ERINLG-261 was obtained in the
form of rough electrophoregrams. The phylogenetic tree obtained
by applying the neighbor joining method is illustrated in Fig. 1. Cul-
ture characteristics and 16S rRNA studies strongly suggested that
our isolate ERINLG-261 belonged to the genus Streptomyces. Studies
on the microbial diversity by 16S rRNA gene analysis showed that
a group of high-GC Gram-positive bacteria (actinomycetes) were
dominant in the soil (Urakawa et al., 1999). The identiﬁcation of iso-
late ERINLG-261 was conﬁrmed as Streptomyces olivochromogenes
with homology of 100%.
Antimicrobial activity of extracts
Streptomyces olivochromogenes (ERINLG-261) was grown in dif-
ferent fermentation media-1 to -4 and extracted with CHCl3, EtOAc
and butanol. Each extracts (fermentation media 1–4) of CHCl3,
EtOAc and butanol were tested against bacteria and fungi. The
EtOAc extract (fermentation media-4) showed good antibacterial
and antifungal activities against tested bacteria and fungi compared
to CHCl3 and butanol extracts (5 mg/ml) (Fig. 2). Secondary metabo-
lite production was checked in different days of incubations with
fermentation media-4. Maximum secondary metabolite produc-
tion was observed on 10th day and it showed good antimicrobial
activity (Fig. 3).
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Fig. 3. Selection of secondary metabolite production using fermentation media-4
(Micromonospora)  at different days of incubation. 10th day showed good secondary
metabolite production and antimicrobial activity.
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solation of active principle
The active principle obtained by preparative HPLC from fraction
 as the major compound gave yellow crystals from methanol
50 mg); it gave a blue color with alcoholic FeCl3 for phenol
nd pink color with alcoholic NaOH. On TLC over silica gel with
tOAc:MeOH (9:1) as the developing system it gave a single
pot (Rf 0.39), yellow in color which on exposure to ammonia
apour turned pink. The compound was C14H8O3 [M + H]+, m/z
25, on the basis of 1H NMR  and 13C NMR  (dept) and Mass. mp
01–302 ◦C [lit. 298–299 ◦C]. UV: max MeOH nm:  225, 249, 278
nd 322. IR: max KBr cm−1: 3413 (hydroxyl), 2952, 2821, 1671
quinone carbonyl), 1618, 1570, 1536, 1373, 1331, 1256, 1223,
175, 1148, 1023, 871, 815, 785 (aromatic). 1H NMR  (ı, CDCl3,
00 MHz): 8.35 (2H, m,  H-5 and H-8), 7.84 (2H, m,  H-6 and H-7),
.42 (1H, d, H-1), 6.82 (1H, d, H-3), 7.08 (1H, s, H-4), 5.14 (1H, s,
H). 13C NMR  (, CDCl3, 100 MHz): 181.2 (C-9, C-10), 152.5 (C-3),
35.1 (C-6, C-7), 133.5 (C-8a, C-10a), 126.6 (C-9a, C-4a), 131.2
C-5, C-8), 130.2 (C-1), 118.5 (C-2), 117.5 (C-4). The 1H and 13C
MR  showed the compound to be 2-hydroxy-9,10-anthraquinone
1). On the basis of the physical and spectroscopic data the
ompound was identiﬁed as 2-hydroxy-9,10-anthraquinone.
hysical and spectroscopic data (UV, FT-IR, 1H NMR, 13C
MR  and MASS) were compared with literature (Saha et al.,
013).
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ig. 4. Cytotoxicity properties of 2-hydroxy-9,10-anthraquinone (1) against
OLO320 cells. Data are mean ± SD of three independent experiments with each
xperiment conducted in triplicate. Positive control-Cyclophosphamide at a con-
entration of 90 ± 0.00156 g/ml (IC50). Farmacognosia 26 (2016) 285–295 291
OH
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1
MIC and MBC values of isolated compound
The compound showed potent antibacterial and antifungal
activities. The MIC  and MBC  values of isolated compound were
seen against E. aerogenes,  S. ﬂexneri,  S. paratyphi-B, K. pneumoniae,
P. aeruginosa,  P. vulgaris and S. typhimurium; some clinical isolates
were E. coli (ESBL-3984), E. coli (ESBL-3904), K. pneumoniae (ESBL-
3971), K. pneumoniae (ESBL-75799), S. aureus (MRSA) and fungi
M. pachydermatis and C. albicans (Table 3). Maximum growth and
pigment production were observed in glucose as the sole source
of carbon. The optimum temperature of 30 ◦C was  found to be
effective for growth and pigment production. Maximum antimi-
crobial compound was obtained at pH 7.0. Earlier report showed
that twelve actinomycetes strains were isolated from the soil sam-
ples of the Himalayas and ERIH-44 showed both antibacterial and
antifungal activity (Duraipandiyan et al., 2010). Normally antibiotic
production was higher in medium having glucose (1%) as car-
bon source. Streptomyces olivochromogenes (ERINLG-261) showed
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Fig. 5. Cytotoxicity properties of 2-hydroxy-9,10-anthraquinone (1) against A549
cells. Data are mean ± SD of three independent experiments with each experiment
conducted in triplicate. Positive control 9.80 ± 0.43 m (IC50) (cisplatin).
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ood antimicrobial activity in Micromonospora medium and indi-
ated that the antimicrobial compounds were extracellular. Most
f the secondary metabolites and antibiotics were extracellular
n nature and extra cellular products of actinomycetes showed
otent antimicrobial activities (Bernan et al., 1994; Hacene et al.,
000). The study of the inﬂuence of different nutritional media and
ulture conditions on antimicrobial compound production indi-
ated that the highest biological activities were obtained when
icromonospora medium was used as a base. In fact, it has been
hown that the nature of carbon and nitrogen sources strongly
ffected antibiotic production in different organisms and the antibi-
tic production was increased by glucose rich medium (Cruz et al.,
999). P. aeruginosa has emerged as one of the most problem-
tic Gram-negative pathogen, with an alarmingly high antibiotic
esistance rate (Bacq-Calberg et al., 1999). Even with the most
ffective antibiotics against this pathogen, namely carbapenems
imipenem and meropenem), the resistance rate was  found to be
5–20.4% amongst 152 P. aeruginosa strains (Savaﬁ et al., 2005).
he present study showed that the isolated compound was  active
gainst P. aeruginosa. This activity might be due to their ability to
omplex with bacterial cell wall (Cowan, 1999) thus, inhibiting the
icrobial growth and the membrane disruption could be suggested
s the mechanism of action (Arvind et al., 2004). The antimicro-
ial compound from Streptomyces olivochromogenes (ERINLG-261)
as recovered using ethyl acetate solvent. Most of the antimi-
robial compounds are extracted using ethyl acetate (Sosio et al.,
000). Moreover, three bioactive compounds of 3-phenylpropionic
cid, anthracene-9,10-quinone and 8-hydroxyquinoline showed
trong antibacterial and antifungal activities (Narayana et al.,
008). Balachandran et al. (2014) had reported 2,3-dihydroxy-9,10-
nthraquinone isolated from Streptomyces galbus (ERINLG-127)
Method validation using crystallised and docked
A
B
Binding mode of compound with active site amin
ig. 6. Putative binding pose of compound 2-hydroxy-9,10-anthraquinone (1) with topoiso
A  – method validation and B – docking with amino acids). Farmacognosia 26 (2016) 285–295
which showed good antimicrobial activity against tested bacte-
ria and fungi. Duraipandiyan et al. (2014) had reported novel
1,5,7-trihydroxy-3-hydroxy methyl anthraquinone isolated from
terrestrial Streptomyces sp. (ERI-26) which showed signiﬁcant
antimicrobial activity against Staphylococcus aureus,  Staphylo-
coccus epidermidis, Bacillus subtilis,  Epidermophyton ﬂoccosum,
Aspergillus niger, Aspergiller ﬂavus,  Trichophyton rubrum and Botrytis
cinerea.
Cytotoxic properties of isolated compound
The isolated compound 2-hydroxy-9,10-anthraquinone (1)
showed moderate cytotoxic activity in vitro against A549 lung and
COLO320 cells. It showed 62.7% activity at the dose of 500 g/ml
with IC50 value of 400 g/ml against COLO320 cells (Fig. 4). Isolated
compound showed 54.7% cytotoxicity against A549 cells at the dose
of 500 g/ml (Fig. 5). All concentrations used in the experiment
decreased the cell viability signiﬁcantly (P < 0.05) in a concentra-
tion dependent manner. A number of anthraquinones have been
reported to possess tumor cell inhibitory effects and are currently
utilized as clinical anticancer agents. Anthraquinones have been
shown to inhibit cancer cells through a variety of mechanisms
including induction of apoptosis, intercalation and binding with
cellular DNA, redox-cycling radical formation, and inhibition of
topoisomerase (Patterson et al., 1983; Fisher et al., 1990; Barasch
et al., 1990; Mueller and Stopper, 1999; Lee et al., 2001; Lee, 2001).
A new, highly oxygenated angucyclin one gephyromycin was iso-
lated from an extract of a Streptomyces griseus strain. Gephyromycin
exhibited glutaminergic activity toward neuronal cells (Bringmann
et al., 2005).
 ligand of DNA Topoisomerase IV (4EMV)
o acids of DNA Topoisomerase IV (4EMV)
merase. Docking of compound 2-hydroxy-9,10-anthraquinone with Topoisomerase
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olecular docking analysis
The compound was subjected to molecular docking studies
sing the AutoDock Tools (ADT) version 1.5.6 and AutoDock version
.2.5.1 docking program (Sanner, 1999) to investigate the poten-
ial binding mode of inhibitor. Molecular docking was performed
ith the DNA Topoisomerase IV (PDB ID: 4EMV), TtgR (PDB ID:
UXO) and beta lactamase (PDB ID: 4NK3) receptors. DNA topo-
somerase IV receptor is required for maintenance of proper DNA
opology during transcription and replication in bacteria. TtgR is
mportant target for antibiotic drugs because antibiotic resistance
s a major problem in antimicrobial drug synthesis. One major
echanism that underlies antibiotic resistance in bacteria is the
ctive extrusion of toxic compounds through the membrane bound
fﬂux pumps that are often regulated at the transcriptional level.
tgR represses the transcription of TtgABC, a key efﬂux pump,
hich is highly resistant to antibiotics (Manchester et al., 2012).
eta-lactams kill bacteria by inhibiting the cell wall construction
nzymes known as PBPs. However, some bacteria have developed
nzymes that can destroy beta-lactams before they can inactivate
he PBPs. These enzymes, known as beta-lactamases, thus enable
he bacteria to survive even in the presence of high concentrations
f beta-lactams. Hence targeting this beta-lactase enzyme is vital
n the antibacterial drug design (Alguel et al., 2007).
In order to verify the reproducibility of the docking calcu-
ations, the bound ligand was extracted from the complex and
ubmitted for one-ligand run calculation. This reproduced top
coring conformation falling within root-mean-square deviation
rmsd) value of 0.65 A˚, 0.74 A˚ and 1.14 A˚ from bound X-ray
Method validation using crystallised an
A
B
Binding mode of compound with active
ig. 7. Putative binding pose of compound 2-hydroxy-9,10-anthraquinone (1) with Ttg
alidation and B – docking with amino acids). Farmacognosia 26 (2016) 285–295 293
conformation of 4EMV, 2UXO and 4NK3 respectively, suggesting
that this method is valid enough to be used for docking studies of
other compounds.
Docking of the compound to DNA Topoisomerase IV, TtgR
and beta lactamase was  performed using AutoDock, following
the same protocol used as in that of validation study. Docking
was taken into 2.5 million energy evaluations were performed
for the test molecule. Docked ligand conformation was analyzed
in terms of energy, hydrogen bonding, and hydrophobic interac-
tion between ligand and receptor. Detailed analyses of the ligand
receptor interactions were carried out, and ﬁnal coordinates of
the ligand and receptor were saved. PyMol software was  used for
display of the receptor with the ligand binding site. From the dock-
ing scores, the free energy of binding (FEB) of the compound was
calculated.
Molecular docking of compound with DNA Topoisome-
rase IV (4EMV) receptor showed the binding energy value of
−7.04 kcal/mol with two hydrogen bonds. In the compound, hydro-
gen of O–H interacts with the C O oxygen of amino acid (ASP-78)
and forms a hydrogen bond with the bond length of 2.2 A˚. Further-
more, oxygen of the one of C O interacts with NH2 hydrogen of
amino acid (ASN-51) and forms a hydrogen bond with the bond
length of 2.2 A˚ (Fig. 6). The compound showed the binding energy
value of −6.85 kcal/mol with two  hydrogen bonds with the docked
TtgR (2UXO) receptor. In the compound, oxygen of O–H interacts
with the N–H hydrogen of amino acid (ASP-172) and forms a hydro-
gen bond with the bond length of 2.7 A˚. Also, hydrogen of the
O–H interacts with the C O oxygen of the amino acid (PHE-168)
and forms a hydrogen bond with the bond length of 2.1 A˚ (Fig. 7).
d docked ligand of TtgR (2UXO)
 site amino acids of TtgR (2UXO)
R. Docking of compound 2-hydroxy-9,10-anthraquinone with TtgR (A – method
294 C. Balachandran et al. / Revista Brasileira de Farmacognosia 26 (2016) 285–295
Method validation using crystallised and docked ligand of beta lactamase (4NK3)
A
B
Binding mode of compound with active site amino acids of beta lactamase (4NK3)
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(ig. 8. Putative binding pose of compound 2-hydroxy-9,10-anthraquinone with B
actamase (A – method validation and B – docking with amino acids).
he compound showed the binding energy value of −6.26 kcal/mol
ith two hydrogen bonds with the docked beta lactamase (4NK3)
eceptor. In the compound, oxygen of O–H interacts with the N–H
ydrogen of amino acid (ARG-175) and forms a hydrogen bond with
he bond length of 2.1 A˚. Also, oxygen of the C O interacts with the
H2 hydrogen of amino acid (ASN-373) and forms a hydrogen bond
ith the bond length of 2.4 A˚ (Fig. 8).
onclusion
Streptomyces olivochromogenes (ERINLG-261) was  isolated from
he soil samples of the Mudumalai hills, Nilgiris, Western
hats of Tamil Nadu, India. Ethyl acetate extract of ERINLG-
61 showed signiﬁcant antimicrobial activities against tested
ram positive and Gram negative bacterial pathogens and ﬁla-
entous fungal pathogens. The bioactivity guided fractionation
f the ethyl acetate led to the isolation of 2-hydroxy-9,10-
nthraquinone (1) as the active principle. The 2-hydroxy-9,10-
nthraquinone was subjected to antimicrobial activity: it showed
ood antimicrobial activity against tested bacteria and fungi. The
-hydroxy-9,10-anthraquinone was also tested against COLO320
nd A549 lung adenocarcinoma cancer cells. The 2-hydroxy-
,10-anthraquinone showed moderate cytotoxic properties against
ested cells. Molecular docking studies of isolated compound 2-
ydroxy-9,10-anthraquinone with enzyme Topoisomerase, TtgR
nd Beta-lactamase showed low binding energy. This is the ﬁrst
eport for the antimicrobial and cytotoxic properties of 2-hydroxy-
,10-anthraquinone isolated from Streptomyces olivochromogenes
ERINLG-261).tamase (4NK3). Docking of compound 2-hydroxy-9,10-anthraquinone with Beta-
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